We have shown that the anti-inflammatory and anti-fibrotic effects of ruscogenin in DN may be attributable to prevention of NF-κB activation, by which inflammatory cell infiltration is abrogated, in turn ameliorating ECM accumulation. The gene discussed is NFKB1; the disease is liver dysplastic nodule.